Factors associated with anxiety among study participants at oncology units in Amhara region hospitals, 2022 (n=392)
| Variables | Anxiety | Crude OR (95% CI) | P value | Adjusted OR (95% CI) | P value | ||
| Yes | No | ||||||
| Sex | Male | 64 | 77 | 1 | 1 | ||
| Female | 160 | 91 | 2.12 (1.39 to 3.22) | <0.001 | 0.74 (0.41 to 1.33) | 0.497 | |
| Marital status | Married | 147 | 110 | 1 | 1 | ||
| Single | 18 | 31 | 0.43 (0.23 to 0.82) | 0.010 | 0.58 (0.22 to 1.53) | 0.271 | |
| Divorced | 32 | 16 | 1.5 (0.78 to 2.86) | 0.223 | 1.50 (0.64 to 3.54) | 0.352 | |
| Widowed | 27 | 11 | 1.84 (0.87 to 3.86) | 0.109 | 1.30 (0.44 to 3.80) | 0.638 | |
| Occupation | Government employed | 29 | 23 | 1 | 1 | ||
| Unemployed | 16 | 13 | 0.97 (0.39 to 2.43) | 0.959 | 1.03 (0.31 to 3.52) | 0.959 | |
| Student | 7 | 12 | 0.47 (0.16 to 1.36) | 0.162 | 0.59 (0.12 to 3.08) | 0.539 | |
| Farmer | 46 | 47 | 0.78 (0.39 to 1.54) | 0.466 | 0.70 (0.26 to 1.90) | 0.487 | |
| Merchant | 48 | 32 | 1.20 (0.59 to 2.41) | 0.630 | 1.21 (0.48 to 3.09) | 0.689 | |
| Housewife | 78 | 41 | 1.51 (0.78 to 2.93) | 0.225 | 1.31 (0.49 to 3.46) | 0.588 | |
| Monthly income | Below 2715 | 156 | 107 | 1.31 (0.86 to 1.99 | 0.215 | 1.37 (0.76 to 2.48) | 0.296 |
| ≥2715 | 68 | 61 | 1 | 1 | |||
| Social support | Poor | 168 | 43 | 10.42 (4.52 to 24.04) | <0.001 | 4.43 (1.7 to 11.5) | 0.002 |
| Moderate | 47 | 101 | 1.24 (0.54 to 2.88) | 0.615 | 0.82 (0.32 to 2.14) | 0.691 | |
| Strong | 9 | 24 | 1 | 1 | |||
| Coffee drinking | Never | 59 | 31 | 1 | 1 | ||
| Daily | 105 | 105 | 0.53 (0.32 to 0.88) | 0.014 | 0.78 (0.38 to 1.63) | 0.520 | |
| Occasionally | 60 | 32 | 0.99 (0.54 to 1.82) | 0.962 | 0.96 (0.42 to 2.23) | 0.939 | |
| Alcohol drinking status | Never drinker | 87 | 59 | 1 | 1 | ||
| Former drinker | 98 | 100 | 0.67 (0.43 to 1.02) | 0.064 | 0.77 (0.43 to 1.37) | 0.368 | |
| Current drinker | 39 | 9 | 2.94 (1.33 to 6.52) | 0.008 | 2.05 (0.78 to 5.42) | 0.147 | |
| Performance status | Good | 109 | 138 | 1 | 1 | ||
| Poor | 115 | 30 | 4.85 (3.02 to 7.79) | <0.001 | 1.97 (1.02 to 3.79) | 0.044 | |
| Treatment type | Chemotherapy | 135 | 72 | 1 | 1 | ||
| Surgery+chemotherapy | 56 | 81 | 0.37 (0.24 to 0.58) | <0.001 | 0.66 (0.34 to 1.29) | 0.226 | |
| Others* | 33 | 15 | 1.17 (0.59 to 2.30) | 0.642 | 0.92 (0.33 to 2.57) | 0.873 | |
| Comorbid disease | No | 190 | 155 | 1 | 1 | ||
| Yes | 34 | 13 | 2.13 (1.09 to 4.18) | 0.027 | 0.94 (0.37 to 2.37) | 0.888 | |
| Cancer stage | Localised cancer | 84 | 87 | 1 | 1 | ||
| Advanced cancer | 140 | 81 | 1.79 (1.19 to 2.69) | 0.005 | 1.18 (0.66 to 2.11) | 0.580 | |
| Cancer type | Gynaecological cancer | 41 | 21 | 1 | 1 | ||
| Breast cancer | 60 | 38 | 0.81 (0.42 to 1.57) | 0.531 | 1.32 (0.52 to 3.35) | 0.560 | |
| Cancer of gastrointestinal tract | 64 | 58 | 0.57 (0.30 to 1.07) | 0.078 | 1.06 (0.41 to 2.75) | 0.901 | |
| Lymphomas | 11 | 12 | 0.47 (0.18 to 1.24) | 0.128 | 0.67 (0.17 to 2.63) | 0.570 | |
| Cancer of skin, bone and soft tissues | 20 | 24 | 0.43 (0.19 to 0.94) | 0.035 | 0.57 (0.18 to 1.80) | 0.336 | |
| Others† | 28 | 15 | 0.96 (0.42 to 2.17) | 0.914 | 1.57 (0.47 to 5.19) | 0.462 | |
| Age | Continuous | 1.021 (1.01 to 1.04) | 0.012 | 0.98 (0.96 to 1.01) | 0.218 | ||
| Pain severity | Continuous | 1.53 (1.39 to 1.69) | <0.001 | 1.30 (1.14 to 1.48) | <0.001 | ||
| Duration of chemotherapy (months) | Continuous | 1.07 (1.03 to 1.12) | 0.001 | 1.03 (0.99 to 1.08) | 0.187 | ||
Bold indicates statistically significant variables.
*Others include (surgery+hormonal therapy, surgery+chemotherapy+hormonal therapy, chemotherapy+radiotherapy, chemotherapy+hormonal therapy).
†Others include (lung cancer, bladder cancer, prostatic cancer, sinonasal cancer, hepatocellular cancer, pharyngeal cancer, testicular cancer, nasopharyngeal cancer, thyroid cancer, laryngeal cancer, pancreatic cancer and cancer of unknown).